Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)Michael Pfreundschuh, Markus Loeffler, Jöerg Schubert et al.|The Lancet Oncology|2008Cited by 1.1k
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNetMiguel Á. Sanz, Francesco Lo‐Coco, Tomoki Naoe et al.|Blood|2008Cited by 957
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNetMiguel Á. Sanz, Francesco Lo‐Coco, Pierre Fenaux et al.|Blood|2019Cited by 655